scholarly journals Alzheimer’s disease and Aβ pathways

2021 ◽  
Vol 12 (3) ◽  
pp. 542-544
Author(s):  
Asem Surindro Singh ◽  
Machathoibi Chanu Takhellambam
Keyword(s):  
United States ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Health Care ◽  
The United States ◽  
Hospital Services ◽  
Health Issues ◽  
Major Health ◽  
Behavioral Issues

Alzheimer's disease (AD) is a neurodegenerative disease which is one of the major health issues globally. It is the 6th cause of death in the United States. Approximately, 60–70% of cases of dementia are caused by AD. The disease advances with age worsening the symptoms that include problems with declining memory, language, mood swings, loss of motivation, self-neglect, and other behavioral issues. AD patients need a long-term health care and hospital services as the disease worsens with the advancing of their age. However, proper medications and treatment is still unavailable as the cause of AD is poorly understood.

Are Health Care Professionals Ready for Alzheimer's Disease: A Comparison of U.S. and Hong Kong Nurses

1994 ◽  
Vol 39 (4) ◽  
pp. 337-351 ◽  
Author(s):  
M. Christine Nagy ◽  
S. Colleen Beal ◽  
Alex Yui-Huen Kwan ◽  
Lorin A. Baumhover
Keyword(s):  
United States ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Health Care ◽  
Hong Kong ◽  
Health Care Professionals ◽  
The United States ◽  
Negative Bias ◽  
Specific Training ◽  
Knowledge Test

The Alzheimer's Disease Knowledge Test (ADK) was administered to samples of practicing nurses in the United States and Hong Kong. Nurses experienced with Alzheimer's Disease patients, having specific training on AD, and reporting greater knowledge about AD were, in fact, more knowledgeable. Overall, U.S. nurses were significantly more knowledgeable, but exhibited more negative bias than Hong Kong nurses. Findings suggest that nurses in Hong Kong, as well as in the United States, need more training about Alzheimer's disease.

Leveraging Technology in Detection of Alzheimer’s Disease: A Systematic Review (Preprint)

2019 ◽  
Author(s):  
Clemens Kruse ◽  
Britney Larson ◽  
Reagan Wilkinson ◽  
Roger Samson ◽  
Taylor Castillo
Keyword(s):  
Magnetic Resonance Imaging ◽  
United States ◽  
Systematic Review ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
The United States ◽  
Diagnostic Process ◽  
Resonance Imaging ◽  
Common Cause ◽  
Key Terms

BACKGROUND Incidence of AD continues to increase, making it the most common cause of dementia and the sixth-leading cause of death in the United States. 2018 numbers are expected to double by 2030. OBJECTIVE We examined the benefits of utilizing technology to identify and detect Alzheimer’s disease in the diagnostic process. METHODS We searched PubMed and CINAHL using key terms and filters to identify 30 articles for review. We analyzed these articles and reported them in accordance with the PRISMA guidelines. RESULTS We identified 11 technologies used in the detection of Alzheimer’s disease: 66% of which used some form of MIR. Functional, structural, and 7T magnetic resonance imaging were all used with structural being the most prevalent. CONCLUSIONS MRI is the best form of current technology being used in the detection of Alzheimer’s disease. MRI is a noninvasive approach that provides highly accurate results in the diagnostic process of Alzheimer’s disease.

380 Projected incidence of Alzheimer's disease in the United States

1996 ◽  
Vol 17 (4) ◽  
pp. S95
Author(s):  
L. Hebert ◽  
P. Scherr ◽  
L. Beckett ◽  
D. Evans
Keyword(s):  
United States ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
The United States

scholarly journals Deaths in the United States among persons with Alzheimer's disease (2010-2050)

2014 ◽  
Vol 10 (2) ◽  
pp. e40-e46 ◽  
Author(s):  
Jennifer Weuve ◽  
Liesi E. Hebert ◽  
Paul A. Scherr ◽  
Denis A. Evans
Keyword(s):  
United States ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
The United States

United States

2019 ◽  
pp. 305-312
Author(s):  
Angela M Lunde ◽  
Ronald C Petersen ◽  
John A Lucas
Keyword(s):  
United States ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Research Funding ◽  
Public Awareness ◽  
The United States ◽  
Care Quality ◽  
National Plan ◽  
Genetic Studies ◽  
Number Of Treatment

In the United States, the National Alzheimer’s Project Act was signed into law in January 2011, and the first National Plan appeared just over 12 months later, with five goals: to prevent and effectively treat Alzheimer’s disease by 2025, to enhance care quality and efficiency, to expand support for people with Alzheimer’s disease and their families, to enhance public awareness and engagement, and to improve data to track progress. The National Plan has seen a rise in research funding (currently standing at US$1.4 billion). Individual states, at the same time, began discussions about initiatives aimed at addressing personal, societal, and financial implications of Alzheimer’s disease. An example is from Minnesota where counselling and support for caregivers are provided, with an estimated saving for the state of Minnesota of US$970 million by 2025. In addition, a number of treatment trials are under way, looking at the effect of monoclonal antibodies on Alzheimer’s disease and a series of genetic studies.

scholarly journals PND57 THE SOCIETAL BURDEN OF PRODROMAL ALZHEIMER’S DISEASE IN THE UNITED STATES

2019 ◽  
Vol 22 ◽  
pp. S280
Author(s):  
K. Saxena ◽  
J. Sullivan ◽  
R. Khandker ◽  
A.S. Ward ◽  
C. Black ◽  
...  
Keyword(s):  
United States ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
The United States ◽  
Societal Burden ◽  
Prodromal Alzheimer’S Disease

Agitation in Demented Patients in the United States

1997 ◽  
Vol 8 (S3) ◽  
pp. 487-490 ◽  
Author(s):  
Jacobo E. Mintzer ◽  
Paul Nietert ◽  
Kerri Costa ◽  
L. Randolph Waid
Keyword(s):  
United States ◽  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Ethnic Groups ◽  
The United States ◽  
Behavioral Disturbances ◽  
Dementing Disorders

Alzheimer's disease and other dementing disorders have been reported in most ethnic groups living in the United States. Although the presence of these disorders in different U.S. ethnic groups is well documented, the characteristics of dementing disorders, such as the presence of behavioral disturbances, in these groups remains unexplored.

Sign in / Sign up

Export Citation Format

Share Document